BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32563123)

  • 1. A gain-of-function mutation in PDR1 of Candida glabrata decreases EPA1 expression and attenuates adherence to epithelial cells through enhancing recruitment of the Mediator subunit Gal11A.
    Tian Y; Zhuang Y; Chen Z; Mao Y; Zhang J; Lu R; Guo L
    Microbiol Res; 2020 Oct; 239():126519. PubMed ID: 32563123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CgPDR1 gain-of-function mutations lead to azole-resistance and increased adhesion in clinical Candida glabrata strains.
    Ni Q; Wang C; Tian Y; Dong D; Jiang C; Mao E; Peng Y
    Mycoses; 2018 Jul; 61(7):430-440. PubMed ID: 29464833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the Adhesin Gene EPA1 Mediated by PDR1 in Candida glabrata Leads to Enhanced Host Colonization.
    Vale-Silva LA; Moeckli B; Torelli R; Posteraro B; Sanguinetti M; Sanglard D
    mSphere; 2016; 1(2):. PubMed ID: 27303714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence modification of the master regulator Pdr1 interferes with its transcriptional autoregulation and confers altered azole resistance in Candida glabrata.
    Tian Y; Gao N; Ni Q; Mao Y; Dong D; Huang X; Jiang C; Li Z; Zhang L; Wang X; Peng Y; Chen C
    FEMS Yeast Res; 2018 Jun; 18(4):. PubMed ID: 29648590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that Ergosterol Biosynthesis Modulates Activity of the Pdr1 Transcription Factor in Candida glabrata.
    Vu BG; Thomas GH; Moye-Rowley WS
    mBio; 2019 Jun; 10(3):. PubMed ID: 31186322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
    Nishikawa JL; Boeszoermenyi A; Vale-Silva LA; Torelli R; Posteraro B; Sohn YJ; Ji F; Gelev V; Sanglard D; Sanguinetti M; Sadreyev RI; Mukherjee G; Bhyravabhotla J; Buhrlage SJ; Gray NS; Wagner G; Näär AM; Arthanari H
    Nature; 2016 Feb; 530(7591):485-9. PubMed ID: 26886795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel downstream regulatory element cooperates with the silencing machinery to repress EPA1 expression in Candida glabrata.
    Gallegos-García V; Pan SJ; Juárez-Cepeda J; Ramírez-Zavaleta CY; Martin-del-Campo MB; Martínez-Jiménez V; Castaño I; Cormack B; De Las Peñas A
    Genetics; 2012 Apr; 190(4):1285-97. PubMed ID: 22234857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous expression of the virulence-related adhesin Epa1 between individual cells and strains of the pathogen Candida glabrata.
    Halliwell SC; Smith MC; Muston P; Holland SL; Avery SV
    Eukaryot Cell; 2012 Feb; 11(2):141-50. PubMed ID: 22140233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive autoregulation and repression of transactivation are key regulatory features of the Candida glabrata Pdr1 transcription factor.
    Khakhina S; Simonicova L; Moye-Rowley WS
    Mol Microbiol; 2018 Mar; 107(6):747-764. PubMed ID: 29363861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional information from clinically-derived drug resistant forms of the Candida glabrata Pdr1 transcription factor.
    Simonicova L; Moye-Rowley WS
    PLoS Genet; 2020 Aug; 16(8):e1009005. PubMed ID: 32841236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sir3 Polymorphisms in Candida glabrata clinical isolates.
    Martínez-Jiménez V; Ramírez-Zavaleta CY; Orta-Zavalza E; de León GD; Gutiérrez-Escobedo G; de León AP; Sifuentes-Osornio J; del Valle MB; De Las Peñas A; Castaño I
    Mycopathologia; 2013 Apr; 175(3-4):207-19. PubMed ID: 23392823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of Candida glabrata Pdr1 by the deubiquitinase subunit Bre5 occurs in a ubiquitin independent manner.
    Paul S; McDonald WH; Moye-Rowley WS
    Mol Microbiol; 2018 Oct; 110(2):309-323. PubMed ID: 30137659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing Candida glabrata Pdr1, a Hyperactive Transcription Factor Involved in Azole Resistance.
    Simonicova L; Moye-Rowley WS
    Methods Mol Biol; 2023; 2658():169-179. PubMed ID: 37024701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain-of-function mutations in PDR1, a regulator of antifungal drug resistance in Candida glabrata, control adherence to host cells.
    Vale-Silva L; Ischer F; Leibundgut-Landmann S; Sanglard D
    Infect Immun; 2013 May; 81(5):1709-20. PubMed ID: 23460523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and ρ0 cells.
    Paul S; Bair TB; Moye-Rowley WS
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6904-12. PubMed ID: 25199772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple interfaces control activity of the Candida glabrata Pdr1 transcription factor mediating azole drug resistance.
    Moye-Rowley WS
    Curr Genet; 2019 Feb; 65(1):103-108. PubMed ID: 30056490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin Loop Formation Induced by a Subtelomeric Protosilencer Represses
    López-Fuentes E; Hernández-Hernández G; Castanedo L; Gutiérrez-Escobedo G; Oktaba K; De Las Peñas A; Castaño I
    Genetics; 2018 Sep; 210(1):113-128. PubMed ID: 30002080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Candida glabrata Upc2A transcription factor is a global regulator of antifungal drug resistance pathways.
    Vu BG; Stamnes MA; Li Y; Rogers PD; Moye-Rowley WS
    PLoS Genet; 2021 Sep; 17(9):e1009582. PubMed ID: 34591857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.